Stockreport

Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration [Yahoo! Finance]

Citius Oncology, Inc.  (CTOR) 
PDF /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR [Read more]